Kacper Odziomek Excels in 2 Pharmacology Courses from Harvard Medical School
Kacper Odziomek, Member of the Student Council at the Polish Space Agency SA, shared a proud post on LinkedIn:
“I am pleased to share that I have earned certificates of achievement in two Pharmacology courses from Harvard Medical School Professional, Corporate, and Continuing Education.
The Clinical Drug Development course explored the full process of bringing new therapeutics from concept to patient, with emphasis on trial design, modern adaptive methodologies, bias and confounding control, data analysis, and the ethical and regulatory frameworks that ensure patient safety.
The Drug Delivery course examined the science and engineering behind optimizing therapeutic delivery, including systemic vs. local administration, overcoming biological barriers, polymeric and nanoparticle carriers, triggerable release systems, and emerging innovations such as closed-loop delivery technologies.
The participation was financed by the Ministry of Science and Higher Education within the project “Support for students in improving their competencies and skills” carried out under the European Funds for Social Development 2021-2027 Programme (FERS.01.05-IP.08-004/23).”
Congratulations to Kacper Odziomek on this outstanding achievement!
More winner stories featured in Hemostasis Today.
-
Jan 8, 2026, 05:51Dominika Jędrzejewska Akbaş Links Sleep Deprivation, Obesity, and Stroke
-
Jan 8, 2026, 05:42Rob Maloney: A Bruise that Did Not Go Away…
-
Jan 8, 2026, 05:33Matías J Alet on Treating Early Neurological Deterioration in Lacunar Stroke
-
Jan 8, 2026, 05:11Thomas Meinel Shares The English Stroke Guidelines 2026
-
Jan 8, 2026, 05:03Hilla Ben-Pazi: We Were Pleased to Receive a Grant from the Israeli Ministry of Economy
-
Jan 8, 2026, 04:24Nikhil Agrawal Breaks Down Perioperative Anticoagulation
-
Jan 8, 2026, 03:58Louise St Germain Bannon Appointed Interim Executive Director of ISTH
-
Jan 8, 2026, 03:47Wolfgang Miesbach on Fernando Corrales-Medina’s Team’s Latest Cross-Sectional Study on Haemophilia
-
Jan 8, 2026, 03:28Rick Matthews: Powerful Perspective from Erin and the NBCA Team